ABVX:EPA
Abivax SA
€ 77.15
arrow_downward
-0.64%(-0.50) Siku 1
6 Nov, 17:36:06 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ABVX...
Fungua
€ 74.45
Juu
€ 77.15
Chini
€ 73.80
Mtaji wa soko
6.84B
Wastani wa kiasi cha mauzo
elfu 111.44
Kiasi cha mauzo ya hisa
elfu 161.37
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Fungua
€ 74.45
Juu
€ 77.15
Chini
€ 73.80
Mtaji wa soko
6.84B
Wastani wa kiasi cha mauzo
elfu 111.44
Kiasi cha mauzo ya hisa
elfu 161.37
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
https://tech-insider.org/
·
dakika 25 zilizopita
AI Sell-Off Wipes $2.5T, Nasdaq Falls 5.52% [2026]
Nacionale
·
dakika 30 zilizopita
How long do Nasdaq corrections last? What happened after the last ones, from 2018 to 2025
RealMoney Pro
·
saa 1 iliyopita
Tech Bounces, but the S&P 500 Still Has Its Worst Week Since April 2025
Fox Business
·
saa 3 zilizopita
Nasdaq rallies as chip stocks recover from brutal losses
Wasifu
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Kuhusu Abivax SA
Afisa Mkuu Mtendaji (CEO)Marc de Garidel | Hartmut J. Ehrlich
Wafanyakazi98
Lilianzishwa4 Des 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutiabivax.com